Merck Immunotherapy Drug Shines In Lung Cancer Study

Posted on: Apr 16, 2018   |   Posted by: Business Mag

Merck Immunotherapy Drug Shines In Lung Cancer Study

Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who...

Continue reading ...



Other Posts from Business Mag